India said on Friday it was working to alleviate a shortage of a medicine used to treat a rare fungal disease hitting Covid-19 patients as its healthcare system reels under a massive wave of coronavirus infections.

Cases of mucormycosis, or "black fungus," a potentially serious condition that causes blurred or double vision, chest pain and breathing difficulties, have surged in India, mostly among Covid-19 patients.